MarketPeel
Insider Trading Intelligence
KA

Karen Akinsanya

SDGR
PRESIDENT OF R&D, THERAPEUTICS · SCHRODINGER, INC. · CIK 0001797672
FILING MIX · LIFETIME43%/57%
BUYS
31
SELLS
41
TOTAL VALUE
$7.37M
COMPANIES
2
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
114,956
AVG SELL PX
$58.73
TRADE KIND
SHOWING 72 / 72
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
27 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Karen Akinsanya, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d27+40.74%-0.44%-0.45%+0.01%+0.84%
14d27+77.78%-2.96%+1.81%-4.78%-6.13%
30d27+81.48%-12.17%+0.87%-13.04%-18.31%
60d27+92.59%-9.16%+5.04%-14.20%-11.77%
90d27+92.59%-18.80%+7.04%-29.06%-29.91%
180d27(2 pending)+44.00%+14.39%+13.29%+1.10%+39.57%
1y27(2 pending)+100.00%-31.83%+21.89%-53.73%-45.10%
2y27(5 pending)+100.00%-52.72%+20.40%-73.11%-83.11%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SDGR · 69,956 shares · as of Mar 5, 2026
050,165100,330150,494200,659202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 31 buys / 41 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 18, 2026Jun 22, 2026View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
1,366$12.90$17.6K69,956Mar 5, 2026Mar 6, 2026View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
27,57673,528Mar 2, 2026Mar 3, 2026View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
6,07745,952Mar 2, 2026Mar 3, 2026View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
24,25039,875Mar 2, 2026Mar 3, 2026View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
48,50048,500Mar 2, 2026Mar 3, 2026View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
2,206$11.99$26.5K71,322Mar 2, 2026Mar 3, 2026View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 23, 2025Jun 24, 2025View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
3,345$25.00$83.6K15,625Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
SALE
President of R&D, Therapeutics
3,3450Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
SALE
President of R&D, Therapeutics
13,3780Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
5,000$25.11$125.6K18,970Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
PURCHASE
President of R&D, Therapeutics
3,345$2.92$9.8K32,348Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
8,378$25.11$210.4K23,970Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
PURCHASE
President of R&D, Therapeutics
13,378$3.22$43.1K29,003Apr 14, 2025Apr 15, 2025View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
62,50062,500Mar 3, 2025Mar 4, 2025View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
15,62515,625Mar 3, 2025Mar 4, 2025View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 14, 2024Jun 17, 2024View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
120,000120,000Mar 4, 2024Mar 5, 2024View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
45,00045,000Jun 15, 2023Jun 16, 2023View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
63,27063,270Feb 9, 2023Feb 10, 2023View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
14,41114,411Jun 15, 2022Jun 16, 2022View →
NAUT
NAUTILUS BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
105,998105,998Mar 30, 2022Mar 31, 2022View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 9, 2022Feb 9, 2022View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,39343,198Oct 15, 2021Oct 19, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,393$55.75$77.7K0Oct 15, 2021Oct 19, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
1,393$4.34$6.0K1,393Oct 15, 2021Oct 19, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,394$61.13$85.2K0Sep 15, 2021Sep 16, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
1,394$4.34$6.0K1,394Sep 15, 2021Sep 16, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,39444,591Sep 15, 2021Sep 16, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
16,047$58.17$933.5K0Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
21,691$57.43$1.25M16,047Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
13,377$3.22$43.1K37,738Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
4,180$4.34$18.1K24,361Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
4,18045,985Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
20,181$17.00$343.1K20,181Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
13,37713,378Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
20,181180,478Aug 16, 2021Aug 17, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
800$76.08$60.9K0Jun 8, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
10,24250,165Jun 8, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
9,442$75.49$712.8K800Jun 8, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
10,242$4.34$44.5K10,242Jun 8, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
6,47960,407Jun 7, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
6,479$4.34$28.1K6,479Jun 7, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
6,479$75.10$486.6K0Jun 7, 2021Jun 9, 2021View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 27, 2021Mar 2, 2021View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
13,37726,755Dec 18, 2020Dec 22, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
13,377$80.00$1.07M0Dec 18, 2020Dec 22, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
13,377$3.22$43.1K13,377Dec 18, 2020Dec 22, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
2,910$67.88$197.5K434Aug 17, 2020Aug 19, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
3,344$2.92$9.8K3,344Aug 17, 2020Aug 19, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
3,3443,345Aug 17, 2020Aug 19, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
100$70.04$7.0K0Aug 17, 2020Aug 19, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
334$68.81$23.0K100Aug 17, 2020Aug 19, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
7,839$67.35$527.9K9,329Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,076$66.66$71.7K2,268Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,972$67.56$133.2K3,669Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
3,3446,689Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
2,697$66.53$179.4K17,168Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
325$68.41$22.2K3,344Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
3,344$2.92$9.8K20,065Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
407$68.17$27.7K0Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
100$65.05$6.5K6,588Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
13,37740,132Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
13,377$3.22$43.1K13,377Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,861$67.53$125.7K407Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
2,641$68.18$180.1K6,688Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
200$65.09$13.0K19,865Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
3,34410,033Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
947$66.73$63.2K5,641Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASE
See Remarks
3,344$2.92$9.8K16,721Aug 12, 2020Aug 14, 2020View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
200,659200,659Feb 10, 2020Feb 10, 2020View →
Other insiders · SDGR
Loading peer insiders…
About this filer
CIK 0001797672
ROLE
President of R&D, Therapeutics
PRIMARY
SDGR
COMPANIES
2
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001797672DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback